---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021392"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:11:51.579727+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# Elite Pharma to release Q2 FY2026 results Nov 14; conference call Nov 17

## Summary
- Q2 FY2026 financial results (ended Sep 30, 2025) to be released on Friday, November 14, 2025.
- Management conference call set for Monday, November 17, 2025, at 11:30 AM EST.
- Dial-in numbers: 1-800-346-7359 (domestic), 1-973-528-0008 (international); conference ID 98840.
- Stockholder questions accepted via email (dianne@elitepharma.com) by deadlines listed in release.

## SEC filing metadata
- accession: 0001493152-25-021392
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 7.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315225021392/0001493152-25-021392-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315225021392/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021392
- JSON: https://secwatch.observer/filing/0001493152-25-021392.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021392.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.